Essential Partners’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.46K Sell
251
-82
-25% -$810 ﹤0.01% 1891
2026
Q1
$3.24K Hold
333
﹤0.01% 1787
2025
Q4
$3.18K Hold
333
﹤0.01% 1618
2025
Q3
$3.25K Buy
+333
New +$2.56K ﹤0.01% 1600

Other funds holding PRTA

Essential Partners's PRTA Position: Q2 2026 in Review

Essential Partners reduced its Prothena Corp (PRTA) stake by 25% in Q2 2026, selling an estimated $810 and leaving 251 shares worth $2.46K. The position accounts for ﹤0.01% of the portfolio, ranked #1891.

Essential Partners first reported a position in PRTA in Q3 2025 and has held it in 4 quarters since. The position peaked at $3.25K in Q3 2025. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Essential Partners held 251 shares of Prothena Corp worth $2.46K as of Q2 2026.
  • Essential Partners sold 82 Prothena Corp shares in Q2 2026, an estimated $810.
  • Prothena Corp made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #1891 holding.
  • Essential Partners first reported a position in Prothena Corp in Q3 2025 and has held it in 4 quarters since.
  • Essential Partners's Prothena Corp position peaked at $3.25K in Q3 2025.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.